In vitro and in vivo antifungal activities and mechanism of heteropolytungstates against Candida species

[1]  C. Ramana,et al.  Fungal cell membrane—promising drug target for antifungal therapy , 2016, Journal of applied microbiology.

[2]  T. Chiller,et al.  The Global Burden of Fungal Diseases. , 2016, Infectious disease clinics of North America.

[3]  S. Zimmerli,et al.  Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. , 2016, Swiss medical weekly.

[4]  Erika Shor,et al.  Coping with Stress and the Emergence of Multidrug Resistance in Fungi , 2015, PLoS pathogens.

[5]  C. Müller,et al.  Polyoxometalates--potent and selective ecto-nucleotidase inhibitors. , 2015, Biochemical pharmacology.

[6]  S. Etcheverry,et al.  Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model. , 2014, Chemico-biological interactions.

[7]  Ziyu Wu,et al.  Broad-spectrum antiviral property of polyoxometalate localized on a cell surface. , 2014, ACS applied materials & interfaces.

[8]  J. Guinea.  Global trends in the distribution of Candida species causing candidemia. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  E. Mylonakis,et al.  Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis. , 2014, Clinical therapeutics.

[10]  L. Cronin,et al.  Engineering polyoxometalates with emergent properties. , 2012, Chemical Society reviews.

[11]  T. Kuno,et al.  A Genomewide Screen in Schizosaccharomyces pombe for Genes Affecting the Sensitivity of Antifungal Drugs That Target Ergosterol Biosynthesis , 2012, Antimicrobial Agents and Chemotherapy.

[12]  L. Jinhua,et al.  Berberine and Itraconazole Are not Synergistic in Vitro against Aspergillus fumigatus Isolated from Clinical Patients , 2011, Molecules.

[13]  T. C. White,et al.  An A643V Amino Acid Substitution in Upc2p Contributes to Azole Resistance in Well-Characterized Clinical Isolates of Candida albicans , 2010, Antimicrobial Agents and Chemotherapy.

[14]  E. Katchburian,et al.  Changes in Cell Wall Synthesis and Ultrastructure during Paradoxical Growth Effect of Caspofungin on Four Different Candida Species , 2010, Antimicrobial Agents and Chemotherapy.

[15]  Yuan-Ying Jiang,et al.  2-Amino-nonyl-6-methoxyl-tetralin muriate inhibits sterol C-14 reductase in the ergosterol biosynthetic pathway , 2009, Acta Pharmacologica Sinica.

[16]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[17]  D. Lyon,et al.  α-, β-, and γ-Dodecatungstosilicic Acids: Isomers and Related Lacunary Compounds , 2007 .

[18]  T. Yamase,et al.  Enhancement of antibacterial activity of beta-lactam antibiotics by [P2W18O62]6-, [SiMo12O40]4-, and [PTi2W10O40]7- against methicillin-resistant and vancomycin-resistant Staphylococcus aureus. , 2006, Journal of inorganic biochemistry.

[19]  J. Rine,et al.  Dual Activators of the Sterol Biosynthetic Pathway of Saccharomyces cerevisiae: Similar Activation/Regulatory Domains but Different Response Mechanisms , 2005, Molecular and Cellular Biology.

[20]  S. Filler,et al.  Mice with disseminated candidiasis die of progressive sepsis. , 2005, The Journal of infectious diseases.

[21]  T. Yamase,et al.  Antibacterial activity of highly negative charged polyoxotungstates, K27[KAs4W40O140] and K18[KSb9W21O86], and Keggin-structural polyoxotungstates against Helicobacter pylori. , 2005, Journal of inorganic biochemistry.

[22]  K. Ying,et al.  cDNA Microarray Analysis of Differential Gene Expression in Candida albicans Biofilm Exposed to Farnesol , 2005, Antimicrobial Agents and Chemotherapy.

[23]  Zhengang Sun,et al.  Synthesis and Biological Activity of Organothiophosphoryl Polyoxotungstates , 2002, Metal-based drugs.

[24]  Xiao-Jun Ma,et al.  Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA Microarray , 2001, Antimicrobial Agents and Chemotherapy.

[25]  C. Nombela,et al.  Virulence genes in the pathogenic yeast Candida albicans. , 2001, FEMS microbiology reviews.

[26]  C. Gill,et al.  Efficacy of the Echinocandin Caspofungin against Disseminated Aspergillosis and Candidiasis in Cyclophosphamide-Induced Immunosuppressed Mice , 2000, Antimicrobial Agents and Chemotherapy.

[27]  T. Yamase,et al.  Inhibitory effect of polyoxotungstates on the production of penicillin-binding proteins and beta-lactamase against methicillin-resistant Staphylococcus aureus. , 1999, Biological & pharmaceutical bulletin.

[28]  T. Yamase,et al.  In vitro antibacterial activity of vanadate and vanadyl compounds against Streptococcus pneumoniae. , 1997, Biological & pharmaceutical bulletin.

[29]  C. Beck-Sague,et al.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.

[30]  P. Domaille,et al.  Trisubstituted heteropolytungstates as soluble metal oxide analogs. III. Synthesis, characterization, phosphorus-31, silicon-29, vanadium-51, and 1- and 2-D tungsten-183 NMR, deprotonation, and proton mobility studies of organic solvent solute forms of HxSiW9V3O40x-7 and HxP2W15V3O62x-9 , 1986 .

[31]  P. Domaille.  The 1- and 2-dimensional tungsten-183 and vanadium-51 NMR characterization of isopolymetalates and heteropolymetalates , 1984 .

[32]  R. Peacock,et al.  Heteropolytungstate complexes of the lanthanide elements. Part II. Electronic spectra: a metal–ligand charge-transfer transition of cerium(III) , 1971 .

[33]  R. Peacock,et al.  Heteropolytungstate complexes of the lanthanide elements. Part I. Preparation and reactions , 1971 .